November 5, 2017Open Access

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Using this sensitive AMH assay, the finding of an undetectable AMH level in women aged >40 at the end of chemotherapy for eBC gave a good prediction that ovarian function would not return. This may allow alterations in post-chemotherapy endocrine management.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Richard A. Anderson

J. Mansi

Robert E. Coleman

Journals

European Journal of Cancer

Actions

Institutions

Imperial College London

University of Edinburgh

King's College London

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider